drugset / Trial / NCT00937391
Contrast-enhanced MRI in Children 2 Months to <2 Years
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
The purpose of this study is to determine pharmacokinetics, safety and efficacy of Magnevist in children 2 months to \< 2 years of age
Timeline
- Start
- 2010-01
- Primary completion
- 2010-09
- Completion
- 2010-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gadopentetate dimeglumine | Diagnostic / imaging agent | 0.05 unknown | Intravenous |
| Subject | Gadopentetate dimeglumine | Diagnostic / imaging agent | 0.1 unknown | Intravenous |
Indications
No indication recorded.